Jane Street Group, LLC Clene Inc. Transaction History

Jane Street Group, LLC

  • $72.9 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$0.26 - $0.55 $5,834 - $12,342
22,440 New
22,440 $6,000
Q4 2022

Feb 14, 2023
BUY
$0.92 - $1.11 $21,251 - $25,639
23,099 New
23,099 $23,000
Q2 2022

Aug 16, 2022
BUY
$2.1 - $4.12 $85,925 - $168,578
40,917 New
40,917 $103,000

Others Institutions Holding CLNN

# of Institutions
54
Shares Held
7.44M
Call Options Held
48.1K
Put Options Held
160K
View Full List

About Clene Inc.

CLNN Quotes by TradingView
  • Ticker CLNN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,502,000
  • Market Cap $21M
  • Description
  • Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral scleros...
More about CLNN
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email